Related Experiment Videos
Neurological aspects of organophosphate poisoning
J L De Bleecker1, J L De Reuck, J L Willems
1Neurology Department, Ghent University Hospital, Belgium.
Abstract:
Besides their well-known anticholinesterase action resulting in a typical acute cholinergic crisis, organophosphorus (OP) agents are capable of producing several subacute or chronic neurological syndromes. The acute over-stimulation at the neuromuscular junction results in muscle fiber necrosis. The significance of this OP-induced myopathy in human intoxication is unknown. Organophosphate-induced delayed neuropathy (OPIDN) arises 1-3 weeks after exposure to some OP compounds all capable of remarkably inhibiting a distinct esterase called neuropathy target esterase (NTE) during a critical time period. An experimental hen model has been designed to screen new OP compounds as to their delayed neurotoxic effects. The recently described intermediate syndrome emerges 1-4 days after an apparently well-treated cholinergic crisis. It main clinical features are sudden respiratory paralysis, cranial motor nerve palsies, and proximal limb muscle and neck flexor weakness. Whether or not this is a separate entity in OP agent toxicology remains to be seen. Further studies are required to further determine its clinical and paraclinical characteristics and the actual type of underlying neuromuscular dysfunction involved.
Insights
Organophosphorus agents cause acute cholinergic crisis and can lead to subacute or chronic neurological syndromes, including delayed neuropathy and a recently identified intermediate syndrome. Further research is needed to understand these complex effects.
Area of Science:
- Neurotoxicology
- Environmental Health
- Pharmacology
Background:
- Organophosphorus (OP) agents are known for acute cholinergic crisis due to anticholinesterase activity.
- OP exposure can also induce subacute or chronic neurological syndromes, including muscle fiber necrosis and organophosphate-induced delayed neuropathy (OPIDN).
Purpose of the Study:
- To investigate the spectrum of neurological syndromes associated with organophosphorus (OP) agent intoxication.
- To characterize the recently described intermediate syndrome following OP exposure.
- To evaluate the utility of an experimental hen model for screening OP compounds for delayed neurotoxic effects.
Main Methods:
- Review of known neurological syndromes caused by organophosphorus agents.
- Description of organophosphate-induced delayed neuropathy (OPIDN) mechanism involving neuropathy target esterase (NTE).
- Introduction of an experimental hen model for screening OP compounds for delayed neurotoxicity.
- Clinical description of the intermediate syndrome emerging after a cholinergic crisis.
Main Results:
- Organophosphorus agents can cause acute muscle fiber necrosis.
- Organophosphate-induced delayed neuropathy (OPIDN) is a distinct syndrome occurring 1-3 weeks post-exposure, linked to NTE inhibition.
- An intermediate syndrome, characterized by respiratory paralysis and nerve palsies, emerges 1-4 days after acute crisis.
Conclusions:
- Organophosphorus agents present a complex toxicological profile beyond acute cholinergic crisis.
- The intermediate syndrome requires further investigation to confirm its distinctness and elucidate underlying neuromuscular dysfunction.
- The hen model provides a valuable tool for assessing the delayed neurotoxic potential of new OP compounds.